These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23484660)

  • 1. [Hydroxychloroquine during pregnancy: a review of retinal toxicity in the newborns].
    Tarfaoui N; Autret-Leca E; Mazjoub S; Cissoko H; Jonville-Béra AP
    Therapie; 2013; 68(1):43-7. PubMed ID: 23484660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M
    J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract]   [Full Text] [Related]  

  • 3. Ocular toxicity of hydroxychloroquine.
    Tehrani R; Ostrowski RA; Hariman R; Jay WM
    Semin Ophthalmol; 2008; 23(3):201-9. PubMed ID: 18432546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy.
    Lai TY; Chan WM; Li H; Lai RY; Lam DS
    Am J Ophthalmol; 2005 Nov; 140(5):794-807. PubMed ID: 16310457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
    Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
    Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
    Lyons JS; Severns ML
    Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of hydroxychloroquine retinopathy.
    Payne JF; Hubbard GB; Aaberg TM; Yan J
    Br J Ophthalmol; 2011 Feb; 95(2):245-50. PubMed ID: 20693556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's the right patient management for early diagnosis of hydroxychloroquine retinal toxicity?
    Giorgi D; Rosati C; Verrastro G; Grandinetti F
    Recenti Prog Med; 1996 Jun; 87(6):308. PubMed ID: 8766959
    [No Abstract]   [Full Text] [Related]  

  • 9. Ophthalmological monitoring for hydroxychloroquine toxicity: a scientific review of available data.
    Silman A; Shipley M
    Br J Rheumatol; 1997 May; 36(5):599-601. PubMed ID: 9189064
    [No Abstract]   [Full Text] [Related]  

  • 10. Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation.
    Motta M; Tincani A; Faden D; Zinzini E; Lojacono A; Marchesi A; Frassi M; Biasini C; Zatti S; Chirico G
    J Perinatol; 2005 Feb; 25(2):86-9. PubMed ID: 15496869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Wolfe F; Marmor MF
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Retinal Toxicity in Longterm Users of Hydroxychloroquine.
    Kim JW; Kim YY; Lee H; Park SH; Kim SK; Choe JY
    J Rheumatol; 2017 Nov; 44(11):1674-1679. PubMed ID: 28864645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine in lupus pregnancy.
    Clowse ME; Magder L; Witter F; Petri M
    Arthritis Rheum; 2006 Nov; 54(11):3640-7. PubMed ID: 17075810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual neurophysiological dysfunction in infants exposed to hydroxychloroquine in utero.
    Renault F; Flores-Guevara R; Renaud C; Richard P; Vermersch AI; Gold F
    Acta Paediatr; 2009 Sep; 98(9):1500-3. PubMed ID: 19500079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Browning DJ
    Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral-domain optical coherence tomography as a screening technique for chloroquine and hydroxychloroquine retinal toxicity.
    Kahn JB; Haberman ID; Reddy S
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):493-7. PubMed ID: 21830746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature.
    Osadchy A; Ratnapalan T; Koren G
    J Rheumatol; 2011 Dec; 38(12):2504-8. PubMed ID: 22002012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimalarial drugs for rheumatoid disease during pregnancy.
    Koren G
    Can Fam Physician; 1999 Dec; 45():2869-70. PubMed ID: 10626050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive series.
    Bienfang D; Coblyn JS; Liang MH; Corzillius M
    J Rheumatol; 2000 Nov; 27(11):2703-6. PubMed ID: 11093457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine Screening Alert: Change is in the Wind.
    Marmor MF
    Ophthalmic Surg Lasers Imaging Retina; 2017 Feb; 48(2):96-98. PubMed ID: 28195610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.